Journal of Immunotherapy and Precision Oncology
POLICIES AND PROCESSES
Editorial Office: email@example.com
Journal of Immunotherapy and Precision Oncology (JIPO) is a peer-reviewed, open-access journal that is published quarterly by Allen Press (Lawrence, KS, USA). The Journal is owned by the Innovative Healthcare Institute (innovativehci.com).
Innovations Journals adhere to the recommendations of the International Committee of Medical Journal Editors (ICMJE, http://www.icmje.org/) and the Committee for Publication Ethics (COPE, https://publicationethics.org/) guidelines to ensure best practices and ethical standards in the conduct and reporting of research and other material published in this Journal.
Additionally, the Journals follow the recommendations of the ICMJE and COPE guidelines for handling complaints and appeals, which includes but is not limited to corrections, retractions, republications, and version control as well as reports of scientific misconduct and other expressions of concern.
Therefore, authors must prepare manuscripts according to the ICMJE recommendations and the instructions herein.
Identifying information should not be published in written descriptions, photographs, sonograms, CT scans, etc., and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian, wherever applicable) gives informed consent for publication. Authors should remove patients' names from figures unless they have obtained informed consent from the patients. The Journals abide by ICMJE guidelines:
1. Authors, not the Journal nor the publisher, need to obtain the patient consent form before the publication and have the form properly archived. The consent forms are not to be uploaded with the cover letter or sent through email to editorial or publisher offices.
2. If the manuscript contains patient images that preclude anonymity, or a description that has obvious indication to the identity of the patient, a statement about obtaining informed patient consent should be indicated in the manuscript.
License and Copyright
Innovations Journals are an open access journals; however, the articles are distributed under the terms of the latest Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) License unless otherwise specified in writing. Under this license, the Journal allows authors and others to share (copy and redistribute) their work for non-commercial purposes, as long as appropriate credit is given. The Journal does not allow modifications to or commercial reuse of the work without permission from the Journal Owner (Innovative Healthcare Institute: innovativehci.com). The Journal permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional/subject-based repository.
- Authors who are college and university faculty or work for corporations should determine whether the author or institutions owns copyright for “work for hire”.
- If the Contribution was prepared as part of the Contributor’s official duties under a government contract or grant for the United States, United Kingdom, Canada, or Australia, then this work is within the public domain and no copyrights may be owned by the author or publisher. The respective government may reproduce, without charge, all portions of the article, and may authorize others to do so for official government purposes. Copyright assignment applies only to the extent allowable by law.
All requests for permission to reprint or modify material published in the Innovations Journals should be directed to the Publishing Manager: firstname.lastname@example.org.
It is the responsibility of authors/contributors to obtain permissions for reproducing any copyrighted material. A copy of the permission obtained must accompany the manuscript. Copies of any and all published articles or other manuscripts in preparation or submitted elsewhere that are related to the manuscript must also accompany the manuscript.
Authorship credit should be based only on substantial contributions to and in accordance with the ICMJE guidelines available at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html
The ICMJE recommends that authorship be based on the following 4 criteria:
1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
2. Drafting the work or revising it critically for important intellectual content; AND
3. Final approval of the version to be published; AND
4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged (see below, “Acknowledgements”).
This Journal follows a strict process for handling authorship changes prior to acceptance or during proof corrections. Authorship changes are not possible after an article is published. To request a change in the author order or for removal or addition of authors, the following process must be followed:
1. An explanation for the change should be submitted to the editors
2. All authors (including those added or removed) must approve the change in writing
Contributors who meet fewer than all 4 of the above criteria for authorship should not be listed as authors, but they should be acknowledged. Examples of activities that alone (without other contributions) do not qualify a contributor for authorship are acquisition of funding; general supervision of a research group or general administrative support; and writing assistance, technical editing, language editing, and proofreading.
All authors must disclose any and all conflicts of interest they may have with publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflict of interests with products that compete with those mentioned in their manuscript.
All source of study-related funding must be disclosed along with the grant number and role of the funder or sponsor in the study (i.e., study design, data analysis, manuscript writing, and any other aspect of the study).
Corresponding Author Role
The corresponding author is the one individual who takes primary responsibility for communication with the Journal during the manuscript submission, peer review, and publication process, and typically ensures that all the Journal’s administrative requirements, such as providing details of authorship, ethics committee approval, clinical trial registration documentation, and gathering conflict of interest forms and statements, are properly completed, although these duties may be delegated to one or more coauthors. The corresponding author should be available throughout the submission and peer review process to respond to editorial queries in a timely way, and should be available after publication to respond to critiques of the work and cooperate with any requests from the Journal for data or additional information should questions about the paper arise after publication.
A manuscript will be reviewed for possible publication with the understanding that it is being submitted to the Journal alone at that point in time and has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. The Journal expects that authors would authorize one of them to correspond with the Journal for all matters related to the manuscript. All manuscripts received are duly acknowledged upon receipt. All authors are asked to verify their authorship at the time of submission, and all authors are included on the final decision letter from the editorial team. All authors are required to sign the copyright transfer form upon acceptance of the manuscript.
On submission, editors review all submitted manuscripts initially for suitability for formal peer review. Manuscripts with insufficient originality, serious scientific or technical flaws, or lack of a significant scientific merits and well-articulated message are rejected without review. Manuscripts that are unlikely to be within the Journal’s scope will be rejected without peer review. Manuscripts that do not comply with the required format, as described herein, would be returned to the authors for technical correction before they undergo peer review.
Note – Innovations Journals only accept manuscripts written in English. A manuscript may be returned without peer review if the paper requires extensive editing for English language. In this case, the authors may seek a professional editing service to make corrections prior to resubmitting.
Before submitting your article, please visit the “Instructions for Authors” page for the chosen Journal. This information will help you understand the requirements for preparing and submitting a manuscript to that Journal. Please note that manuscripts not conforming to the Journal’s instructions may be returned without review.
To submit an article, all Innovations Journals use an online manuscript processing system for receiving and processing article submissions. All authors are required to register with their name, email, and institution information. You will find the link to the submission website from the “Instructions for Authors” page for the chosen journal.
Manuscripts that are considered for publication in this Journal are sent to at least two expert reviewers, with the exception of editorials, commentary, and letters. During submission, the submitting author is requested to provide names of three qualified reviewers who have experience in the subject of the submitted manuscript, but this is not mandatory. The suggested reviewers should not be affiliated with the same institutes as the authors. The selection of these reviewers is at the sole discretion of the editor.
The Journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other’s identity. Every manuscript is also assigned to a member of the editorial team (Editor in Chief, Associate Editor, or Guest Editor) who, based on the comments from the reviewers, takes a final decision on the manuscript. The comments and suggestions (acceptance/ rejection/ amendments or revisions in manuscript) received from reviewers are conveyed to the corresponding author. If required, the author is requested to provide a point-by-point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated until the reviewers and editors are satisfied with the response and associated changes in the manuscript.
A Guest Editor is assigned in certain situations to avoid a potential conflict of interest. These situations include manuscripts authored by a member of the editorial team and manuscripts authored by individuals affiliated with the same institution as the Editor in Chief. A Guest Editor may also be assigned for manuscripts about special topics or issues outside the expertise of the editorial team.
Manuscripts accepted for publication are copyedited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within 3 business days. The whole process of submission of the manuscript to final decision and sending and receiving proofs is completed online.
The Journal publishes articles on its website upon acceptance (article title only) immediately following proof corrections (full manuscript) and follows a continuous publication’ schedule. Articles are compiled for ‘print on demand’ quarterly issues.
The Journal does not charge fees for the submission, processing, or publication of manuscripts.
The Journal may charge fees for access to the Journal in the form an annual subscription and/or download fees.).